Nuwellis Files 8-K for 'Other Events' and Exhibits
Ticker: NUWE · Form: 8-K · Filed: Feb 6, 2024 · CIK: 1506492
| Field | Detail |
|---|---|
| Company | Nuwellis, Inc. (NUWE) |
| Form Type | 8-K |
| Filed Date | Feb 6, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: corporate-filing, other-events, administrative
TL;DR
**Nuwellis filed an 8-K, signaling upcoming news that could move the stock.**
AI Summary
Nuwellis, Inc. filed an 8-K on February 6, 2024, to report "Other Events" and "Financial Statements and Exhibits." This filing, under the ticker NUWE on the Nasdaq Capital Market, indicates that the company is providing updates on its operations or financial status, though the specific details of these events are not elaborated in the provided excerpt. For investors, this matters because 8-K filings often precede significant news, such as new contracts, leadership changes, or financial results, which can impact the stock's valuation and future prospects.
Why It Matters
This 8-K signals that Nuwellis, Inc. has new information to disclose, which could range from operational updates to financial developments, potentially influencing investor sentiment and stock price.
Risk Assessment
Risk Level: medium — The filing itself is administrative, but the undisclosed 'Other Events' could carry either positive or negative implications, creating uncertainty.
Analyst Insight
A smart investor would monitor Nuwellis's news releases closely for the specific details of the 'Other Events' and 'Financial Statements and Exhibits' to understand their potential impact on the company's future performance and stock price.
Key Numbers
- 001-35312 — SEC File Number (identifies Nuwellis's registration with the SEC)
- 16 — Public Document Count (number of documents associated with this filing)
- $0.0001 — Par Value per Share (the nominal value of each common stock share)
Key Players & Entities
- Nuwellis, Inc. (company) — the registrant filing the 8-K
- Nasdaq Capital Market (company) — the exchange where Nuwellis's common stock is registered
- February 6, 2024 (date) — the date of the earliest event reported in the 8-K
- 001-35312 (dollar_amount) — Commission File Number for Nuwellis, Inc.
- $0.0001 (dollar_amount) — par value per share of Nuwellis Common Stock
Forward-Looking Statements
- Nuwellis will release specific details about the 'Other Events' mentioned in the 8-K within the next few weeks. (Nuwellis, Inc.) — medium confidence, target: 2024-03-01
- The 'Other Events' could relate to a new product development or a significant partnership. (Nuwellis, Inc.) — low confidence, target: 2024-03-01
FAQ
What is the primary purpose of Nuwellis, Inc.'s 8-K filing on February 6, 2024?
The primary purpose of Nuwellis, Inc.'s 8-K filing on February 6, 2024, is to report 'Other Events' and 'Financial Statements and Exhibits' as per the 'ITEM INFORMATION' section of the filing.
On which stock exchange is Nuwellis, Inc.'s common stock traded?
Nuwellis, Inc.'s common stock, with the trading symbol NUWE, is registered on the Nasdaq Capital Market, as stated under 'Name of each exchange on which registered'.
What is the par value of Nuwellis, Inc.'s common stock?
The par value of Nuwellis, Inc.'s common stock is $0.0001 per share, as indicated in the 'Title of each class' section for 'Common Stock'.
What is the business address and phone number of Nuwellis, Inc.?
Nuwellis, Inc.'s business address is 12988 Valley View Road, Eden Prairie, MN 55344, and its business phone number is (952) 345-4200, according to the 'BUSINESS ADDRESS' and 'BUSINESS PHONE' sections.
Has Nuwellis, Inc. operated under different names in the past?
Yes, Nuwellis, Inc. has operated under former names. It was previously known as CHF Solutions, Inc. (name changed on 20170523) and Sunshine Heart, Inc. (name changed on 20101124), as detailed in the 'FORMER COMPANY' sections.
Filing Stats: 495 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-02-06 09:07:29
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share NUWE Nasdaq Capital Marke
Filing Documents
- ny20017086x5_8k.htm (8-K) — 26KB
- ny20017086x5_ex99-1.htm (EX-99.1) — 17KB
- logo_nuwellis.jpg (GRAPHIC) — 3KB
- 0001140361-24-005784.txt ( ) — 184KB
- nuwe-20240206.xsd (EX-101.SCH) — 4KB
- nuwe-20240206_lab.xml (EX-101.LAB) — 22KB
- nuwe-20240206_pre.xml (EX-101.PRE) — 16KB
- ny20017086x5_8k_htm.xml (XML) — 4KB
01
Item 8.01 Other Events. On February 6, 2024, Nuwellis, Inc. issued a press release announcing the publication of new data demonstrating the potential value of the Aquadex SmartFlow system's aquapheresis therapy when treating patients with fluid overload as a result of end-stage liver disease. A copy of this press release is filed herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Information contained on or accessible through any website reference in the press release is not part of, or incorporated by reference in, this Current Report on Form 8-K, and the inclusion of such website addresses in this Current Report on Form 8-K by incorporation by reference of the press release is as inactive textual references only.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Number Description 99.1 Press Release, dated February 6 , 2024 104 Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 6, 2024 NUWELLIS, INC. By: /s/ Nestor Jaramillo, Jr Name: Nestor Jaramillo, Jr. Title: President and Chief Executive Officer